SARAH HERBEL
Allopathic & Osteopathic Physicians|Emergency Medicine COUSHATTA, LA NPI 1508488024
Browse related groups: Allopathic & Osteopathic Physicians|Emergency Medicine LA Bayer HealthCare Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$155.91
- Category: General Payments
- Program years: PY2023–2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $133.03 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $133.03 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $59.47 | 3 |
| ABBVIE INC. | $21.37 | 1 |
| Mylan Specialty L.P. | $18.10 | 1 |
| Averitas Pharma Inc. | $17.24 | 1 |
| Novo Nordisk AS | $16.85 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086130306 | Bayer Healthcare Pharmaceuticals Inc. | $21.83 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086165042 | Bayer Healthcare Pharmaceuticals Inc. | $21.12 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086212517 | Bayer Healthcare Pharmaceuticals Inc. | $16.52 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096847077 | Novo Nordisk Inc | $16.85 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103907564 | ABBVIE INC. | $21.37 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133429456 | Averitas Pharma Inc. | $17.24 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147305142 | Mylan Specialty L.P. | $18.10 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.